Effects of hormonal replacement treatment on bone mineral density and metabolism in hypogonadal patients

Mol Cell Endocrinol. 2000 Mar 30;161(1-2):47-51. doi: 10.1016/s0303-7207(99)00223-3.

Abstract

We investigated 22 male patients affected by prepubertal hypogonadism with a mean age of 34.3+/-5.2. A significant reduction of bone mineral density (BMD) at both the lumbar spine (L2-L4, -14%, 1.039+/-0.11 vs. 1.217+/-0.16 g/cm(2), P=0.005) and femoral neck (-11%; 0.927+/-0.09 vs. 1.034+/-0.16 g/cm(2), P=0.01) was found in patients compared to age-matched controls. The mean Z score was -1. 55 for vertebrae and -1.33 for femur. Eleven and nine patients, respectively, had a lumbar and femoral BMD at least 1 S.D. below the normal mean; 8 and 4, respectively, 2 S.D. below. There was a strong positive correlation between BMD and duration of hormone replacement treatment (HRT) for both sites: respectively, r=0.71, P<0.005 for the vertebrae, and r=0.60, P<0.01 for the femur. A weak correlation was also present between onset of HRT and BMD: r=0.6, P<0.01 at the lumbar level, and r=0.47, P<0.05 at the femoral neck.

MeSH terms

  • Adult
  • Age of Onset
  • Bone Density / drug effects*
  • Bone Remodeling / drug effects
  • Case-Control Studies
  • Femur Neck
  • Hormone Replacement Therapy*
  • Humans
  • Hypogonadism / congenital
  • Hypogonadism / drug therapy
  • Hypogonadism / metabolism*
  • Linear Models
  • Lumbosacral Region
  • Male
  • Matched-Pair Analysis
  • Testosterone / administration & dosage
  • Testosterone / blood
  • Testosterone / urine

Substances

  • Testosterone